Heart valvular disease in patients with Parkinson's disease treated with high-dose pergolide

被引：102
|
作者：
Van Camp, G
Flamez, A
Cosyns, B
Goldstein, J
Perdaens, C
Schoors, D
机构：
[1] Free Univ Brussels, Akad Ziekenhuis, Dept Cardiol, B-1090 Brussels, Belgium
[2] Free Univ Brussels, Dept Neurol, B-1090 Brussels, Belgium
[3] Free Univ Brussels, Dept Cardiac Surg, B-1090 Brussels, Belgium
[4] Free Univ Brussels, Dept Pathol, B-1090 Brussels, Belgium
来源：
NEUROLOGY | 2003年 / 61卷 / 06期
关键词：
D O I：
10.1212/01.WNL.0000083985.00343.F2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors report the clinical, echocardiographic, and pathologic findings in two patients treated with more than 5 mg of pergolide daily who developed symptomatic severe heart failure due to restrictive valvular disease. They also describe the echocardiographic data of another eight patients taking similar doses of pergolide presenting no clinical signs of heart failure. The findings suggest a possible role of high doses of pergolide in inducing restrictive valvular disease.
引用
收藏
页码：859 / 861
页数：3
相关论文
共 50 条
  • [1] Valvular heart disease in patients with Parkinson's disease treated with pergolide
    Dupuy, D.
    Lesbre, J. P.
    Andrejak, M.
    Godefroy, O.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 59 - 59
  • [2] Valvular heart disease in patients with Parkinson's disease treated with pergolide
    Dupuy, D.
    Lesbre, J. P.
    Andrejak, M.
    Godefroy, O.
    [J]. DRUG SAFETY, 2006, 29 (10) : 1005 - 1005
  • [3] Heart valvular disease in patients with Parkinson's disease treated with Pergolide and/or Levodopa
    Ozer, F.
    Tiras, R.
    Cetin, S.
    Ozturk, O.
    Aydemir, T.
    Ozben, S.
    Meral, H.
    Kizkin, S.
    Bader, H.
    [J]. MOVEMENT DISORDERS, 2006, 21 : S518 - S518
  • [4] Valvular heart disease is rare in Parkinson's disease patients treated with pergolide
    Ruzicka, E.
    Linkova, H.
    Penicka, M.
    Roth, J.
    Ulmanova, O.
    Novakova, L.
    Havlikova, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 82 - 82
  • [5] Valvular heart disease in patients with Parkinson's disease treated with pergolide, levodopa or both
    Ozer, Feriha
    Tiras, Raziye
    Cetin, Sibel
    Ozturk, Oya
    Aydemir, Tuba
    Ozben, Serkan
    Meral, Hasan
    Kizkin, Sibel
    Bader, Halit
    Ozben, Beste
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2009, 16 (01) : 83 - 87
  • [6] Clinically relevant valvular heart disease is rare in Parkinson's disease patients treated with pergolide
    Linkova, Hana
    Penicka, Martin
    Ruzicka, E.
    Roth, J.
    Ulmanova, O.
    Novakova, L.
    Havlikova, Martina
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 303A - 303A
  • [7] Valvular heart disease in a patient with Parkinson's disease treated with a low daily dose and a low cumulative dose of pergolide
    Chung, EJ
    Yoon, WT
    Kim, JY
    Lee, WY
    [J]. MOVEMENT DISORDERS, 2006, 21 (04) : 586 - 587
  • [8] Valvular heart disease in patients with Parkinsons disease treated with pergolide
    Van Camp, G
    Cosyns, B
    Flamez, A
    Goldstein, J
    Perdaens, C
    Schoors, D
    [J]. EUROPEAN HEART JOURNAL, 2003, 24 : 648 - 648
  • [9] Valvular heart disease in patients with Parkinson’s disease treated with pergolide. Course following treatment modifications
    D. Dupuy
    J. P. Lesbre
    P. Gérard
    M. Andrejak
    O. Godefroy
    [J]. Journal of Neurology, 2008, 255
  • [10] Valvular heart disease associated with low cumulative dose of pergolide in the patient with Parkinson's disease
    Chung, EJ
    Lee, WY
    [J]. MOVEMENT DISORDERS, 2005, 20 : S84 - S84
12345